Ella Therapeutics

Ella TherapeuticsElla Therapeutics
Ella Therapeutics

Ella Therapeutics

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Website
2019Active4
Rate
Advertise here

About

Ella Therapeutics is a biotechnology company focused on developing novel microbiome-derived therapies to address resistance to immune checkpoint inhibitors (ICIs) in cancer treatment. Their research utilizes a unique Reverse Clinical Development method to identify and characterize specific microbial agents that can enhance the efficacy of existing cancer immunotherapies.

Technology stack

detected 2026-07-04
EmailGoogle Workspace
Hosting
self_managed
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Ella Therapeutics do?

Ella Therapeutics is a biotechnology company focused on developing novel microbiome-derived therapies to address resistance to immune checkpoint inhibitors (ICIs) in cancer treatment. Their research utilizes a unique Reverse Clinical Development method to identify and characterize specific microbial agents that can enhance the efficacy of existing cancer immunotherapies.

Where is Ella Therapeutics headquartered?

Ella Therapeutics is headquartered in Boston, United States.

When was Ella Therapeutics founded?

Ella Therapeutics was founded in 2019.

What industry does Ella Therapeutics operate in?

Ella Therapeutics operates in Life Sciences, Immunotherapy, Microbiome, Computational Biology, Healthcare, Biotech.

How many employees does Ella Therapeutics have?

Ella Therapeutics has approximately 4 people on record.

What is Ella Therapeutics's revenue?

StartupHub estimates Ella Therapeutics's annual revenue at $703K (range $381K to $1.1M, 64% confidence), based on comparable companies in the sector.